Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.

Psoriasis is associated with obesity accompanied by insulin resistance. A recent study disclosed increased plasma resistin and decreased plasma omentin levels in obesity. Few studies of plasma levels of resistin and omentin are available in psoriasis. We analyzed plasma levels of resistin and omentin in psoriasis and compared them with those of healthy controls. Evaluation of plasma levels of resistin and omentin was performed by enzyme-linked immunosorbent assay (ELISA) for 62 psoriasis patients and 58 healthy controls. The severity of psoriasis was evaluated by psoriasis area and severity index (PASI) score. Plasma levels of resistin were significantly increased in psoriasis as compared with those of healthy controls. In contrast, plasma levels of omentin were significantly decreased in psoriasis patients. Plasma levels of resistin and omentin were positively and negatively correlated with PASI scores, respectively. After the treatment of psoriasis, resistin levels were decreased and omentin levels were increased, respectively, compared with those of pretreated. Plasma levels of resistin and omentin might be useful for evaluating the disease activity of psoriasis.
AuthorsHidetoshi Takahashi, Hitomi Tsuji, Masaru Honma, Akemi Ishida-Yamamoto, Hajime Iizuka
JournalArchives of dermatological research (Arch Dermatol Res) Vol. 305 Issue 2 Pg. 113-6 (Mar 2013) ISSN: 1432-069X [Electronic] Germany
PMID23291856 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Cytokines
  • GPI-Linked Proteins
  • ITLN1 protein, human
  • Lectins
  • Resistin
  • Adult
  • Aged
  • Biomarkers (blood)
  • Cytokines (blood)
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • GPI-Linked Proteins (blood)
  • Humans
  • Japan
  • Lectins (blood)
  • Male
  • Middle Aged
  • Obesity (diagnosis, epidemiology)
  • Psoriasis (diagnosis, epidemiology)
  • Resistin (blood)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: